Posted by Michael Wonder on 11 Oct 2021
OIA documents prove PHARMAC's independent inquiry is a toothless whitewash
11 October 2021 - Following a damning survey of PHARMAC, National can also reveal documents received under OIA show the delayed independent inquiry into the national drug purchasing agency is a toothless whitewash and another nail in the coffin for Andrew Little, says National’s Health spokesperson Dr Shane Reti.
“OIA documents show that, prior to the health budget this year, officials were recommending that Andrew Little defer the $200 million PHARMAC package to 2022 or 2023, so that findings of the independent review could be taken into account. Instead, Andrew Little went ahead despite knowing there would be no money to act on any recommendations arising from the inquiry.
